Skip to content

somraji tail ka twak kandu par prabhav

A Pharmaceutico - Analytical study of Somaraji Tailam and its Effects on Dadru

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051965
Enrollment
30
Registered
2023-04-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue Health Condition 2: L089- Local infection of the skin and subcutaneous tissue, unspecified Health Condition 3: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Goverment Ayurvedic college,Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: On the basis of symptoms seen in Dadru Eruptions, Circular shape of Patches, Pidika , Etching etc.

Exclusion criteria

Exclusion criteria: Dadru with associated complications Patients suffering from chronic disease like AIDS, Cancer, TB and cardiac Complication etc.

Design outcomes

Primary

MeasureTime frame
reduction of itching pidikaTimepoint: 90 days

Secondary

MeasureTime frame
relief in symptoms like Kandu(Itching) Pidika etc of dadruTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Neetu Singh

Govt Ayurvedic College Patna

singhneetu17@gmail.com7091141115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026